Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Preprandial Ghrelin on Postprandial Glucose Tolerance
NCT02913703Phase 1Completed
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1 trial of human ghrelin in type 2 diabetes mellitus (T2DM) (6 arms). Primary endpoint: Glucose tolerance. Started Jan 2017; status: completed.
02
Drugs
human ghrelin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02913703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02913703.